SINGAPORE — Louis Dreyfus Company Asia Pte. Ltd. (LDC) has agreed to acquire Emerald Grain Pty. Ltd. from Longriver Farms. Emerald Grain has been a subsidiary of Longriver Farms since December 2020, when it was acquired from Japan’s Sumitomo Corp.

Emerald Grain is a grain handling business in Australia, with a network of seven grain storage and receival sites across the states of New South Wales and Victoria, with a combined storage capacity of approximately 1 million tonnes, as well as a grain export terminal at the Port of Melbourne and marketing offices in Geraldton, Western Australia and Moama, New South Wales.

“This development is aligned with LDC’s commitment to the Australian market, where LDC has been active for over a century, originating, processing and exporting grains, oilseeds and cotton, and with our strategic plans to further reinforce our leading position in core agri-commodities merchandizing activities,” said Michael Gelchie, chief executive officer of LDC.

Brad Mytton, director of Longriver Farms, added: “I want to thank Emerald Grain’s management team and staff for their significant contribution to the successful growth partnership to date with Longriver Farms. We are pleased to announce this agreement with LDC, under which Emerald Grain’s grower and customer network will benefit from LDC’s scale and expertise in agri-commodities, for a continued growth journey going forward.”

He noted that Emerald Grain’s ties to some 10,000 Australian farming families, its integrated supply chain and an experienced and dedicated team offers customers a broad range of grains products, including wheat, barley and canola, for export across Australia.

“This agreement is an opportunity for all Australian growers in our network to access LDC’s extensive global reach,” said David Johnson, CEO of Emerald Grain. “LDC’s leadership position in the global agriculture industry reflects its commitment to growers and customers alike, and we look forward to continuing our journey as part of the LDC family.”

The agreement is subject to regulatory approvals and customary closing conditions.